Schwab Options Turn Defensive as Targets Fall Further

SCHW has lost another 1.7% over the past week to $89.30, underperforming the median gain of 0.8% among its closest peers, as options traders grow more cautious and the Street continues to trim its expectations following the Q3 earnings miss.

The sharpest signal this week comes from options. The put/call ratio jumped to 1.01 on October 27, well above its 20-day average of 0.92 and nearly three standard deviations from that mean, the most defensive reading in months. That is a meaningful reversal from two weeks ago, when the PCR had dropped to 0.88 in what looked like opportunistic call-buying after the initial post-results selloff. Investors who were leaning into the dip with calls have rotated back toward downside protection. Short interest, by contrast, gives little cause for alarm. At under 1% of the free float and down 10% on the week, it continues to fall. Borrow cost ticked up sharply to 0.61% from 0.34% a week earlier, a 64% jump, though it remains low in absolute terms. Availability is effectively unlimited, with over 1.7 billion shares available to lend.

The analyst community is still adjusting its views post-Q3. Evercore ISI cut its target again this week, to $98 from $104, while Morgan Stanley had already lowered to $132 from $141 on October 21. Both maintained their existing ratings. The pattern across the Street is consistent: firms are holding their ratings but ratcheting down price targets, a signal that conviction on direction remains but the near-term earnings power story has been reset. The mean consensus target now sits at $117.32, implying roughly 31% upside from current levels. That gap is wide, but the path to closing it is what the market is debating. The bear case centres on the Q4 net interest margin guide of 3.15% to 3.20%, which management framed as less of an uplift than investors had anticipated, alongside a greater need for wholesale funding and modest improvement in interest-earning assets. The bull case points to the underlying franchise: Q3 core net new assets rose 38% year-on-year to a record $190.4 billion, active brokerage accounts reached 40.3 million, and bank loans grew 35%. The PE multiple has compressed to 11.8x, down over a point in the past 30 days, and price-to-book has fallen to 2.9x, making the valuation argument more straightforward even if the NIM timeline is uncertain.

FDIC call report data tracked by ORTEX Alt Data shows that net loans and leases at Schwab's insured bank charters have risen for nine consecutive quarters, reaching $67.2 billion as of the April 2026 period, and quarterly net income has grown for seven straight quarters, reaching $1.0 billion in the same period. The FDIC dataset has not yet been tested against Schwab's reported figures as a lead indicator, so these readings are context rather than a read on the next print. They do, however, corroborate the bull case that the underlying bank business has been expanding steadily through a period when the market has focused heavily on the balance sheet's rate sensitivity.

The insider register adds one notable data point. Co-Chairman Walter Bettinger sold 74,388 shares on August 28 at roughly $110.91 each, a transaction valued at approximately $8.25 million and filed without a 10b5-1 plan, giving it more weight as a discretionary decision. The sale came when the stock was around $111, compared with $89.30 today. Net insider activity over the past 90 days is a net sale of just over one million shares worth approximately $112 million, though much of that reflects option exercises paired with sales under pre-arranged plans. The Charles and Helen Schwab Living Trust, the founder's family vehicle, held 49.9 million shares as of July 24 with no reported change, representing a stable anchor position at roughly 2.9% of shares outstanding.

Among correlated peers, RJF and AMP both gained around 1% to 2% on the week, while SEIC fell 4% and LPLA dropped 1.3%. Schwab's 1.7% decline puts it toward the bottom of its peer group for the week, consistent with the post-earnings repricing that has now taken the stock down roughly 10% over the past month. The next scheduled earnings event is January 15, 2027, 79 days away. Between now and then, the question is whether Q4 NIM data and client cash dynamics unfold closer to the bull or bear framing the Street has been debating since mid-October.